" class="no-js "lang="en-US"> CRISPR QC Co-founder Kiana Aran Makes Female Founders List
Thursday, June 08, 2023

CRISPR QC Co-founder Kiana Aran Makes Inc.’s 2023 Female Founders List

CRISPR QC is proud to announce that co-founder Kiana Aran has been recognized by Inc. magazine as a top 200 Female Founder. This prestigious list highlights women entrepreneurs who are making a significant impact in their respective industries and driving change.

Dr. Kiana Aran is a world-renowned bioengineer and innovator; she co-founded CRISPR QC with the mission to provide cutting-edge tools and technologies for CRISPR research and development. Dr. Aran is the inventor of the CRISPR-Chip, a groundbreaking technology that enables real-time, direct measurements of CRISPR activity that can advance sustainable agriculture and gene therapy development.

“As a female founder, I hope to inspire other women to have the courage and intellectual bravery to pursue their entrepreneurial goals,” says Dr. Aran. “The development of CRISPR-Chip technology has proven to be incredibly valuable for the CRISPR industry, and I am thrilled to see the impact of my work. This recognition from Inc. magazine is incredibly rewarding and motivates me to continue pushing boundaries in biotechnology innovations. I am excited to further bridge the gap between the benches in my academic lab and effective commercial applications.”

CRISPR QC congratulates Kiana Aran on this well-deserved recognition on Inc.’s 2023 Female Founders List and looks forward to her continued leadership.

  1. New “AI Doctor” Predicts Hospital Readmission and Other Health Outcomes Read more
  2. Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease Read more
  3. MedTech Innovator Asia Pacific Names 24 Startups to Annual Accelerator Read more
  4. XNK Therapeutics Appoints Hugo Petit as Chief Financial Officer Read more
  5. Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics Read more